يعرض 1 - 10 نتائج من 18 نتيجة بحث عن '"новообразования поджелудочной железы"', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Medical Visualization; Том 24, № 1 (2020); 13-28 ; Медицинская визуализация; Том 24, № 1 (2020); 13-28 ; 2408-9516 ; 1607-0763

    وصف الملف: application/pdf

    العلاقة: https://medvis.vidar.ru/jour/article/view/850/584Test; https://medvis.vidar.ru/jour/article/view/850/585Test; Gordon-Dseagu V.L., Devesa S.S., Goggins M., Stolzenberg-Solomon R. Pancreatic cancer incidence trends: Evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int J Epidemiol 2017; 47.2: 427-439. https://doi.org/10.1093/ije/dyx232Test.; Papavramidis T., Papavramidis S. Solid Pseudopapillary Tumors of the Pancreas: Review of 718 Patients Reported in English Literature. J Am Coll Surg 2005; 200(6): 965-72. https://doi.org/10.1016/j.jamcollsurg.2005.02.011Test; Rindi G., Bordi C. Highlights of the biology of endocrine tumours of the gut and pancreas. Endocr Relat Cancer 2003; 10(4): 427-36. https://doi.org/10.1677/erc.0.0100427Test.; Massironi S., Sciola V., Peracchi M., Ciafardini C., Spampatti M.P., Conte D. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol 2008; 14: 5377–5384. https://doi.org/10.3748/wjg.14.5377Test.; Ehehalt F., Saeger H.D., Schmidt C.M. et al. Neuroendocrine Tumors of the Pancreas LEARNING OBJECTIVES. Oncologist 2009; 140014(5):456-467. https://doi.org/10.1634/theoncolo-gist.2008-0259Test.; Tang L.H., Untch B.R., Reidy D.L. et al. Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: A pathway distinct from poorly differentiated neuroendocrine carcinomas. Clin Cancer Res 2016; 22(4): 1011-1017. https://doi.org/10.1158/1078-0432.CCR-15-0548Test; Tang L.H., Basturk O., Sue J.J., Klimstra D.S. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. Am J Surg Pathol 2016; 40(9): 1192-1202. https://doi.org/10.1097/PAS.0000000000000662Test.; Tang X., Zhang X., Che X., Chen Y., Wang C. Peripancreatic lymphadenopathy on preoperative radiologic images predicts malignancy in pancreatic solid pseudopapillary neoplasm. Int J Clin Exp Med 2015; 8(9): 16315-21. PMID: 26629150.; Choi J.Y., Kim M.J., Kim J.H. et al. Solid pseudopapillary tumor of the pancreas: typical and atypical manifestations. Am J Roentgenol 2006; 187(2): 178-86. https://doi.org/10.2214/AJR.05.0569Test.; Naar L., Spanomichou D.A., Mastoraki A., Smyrniotis V., Arkadopoulos N. Solid Pseudo-papillary Neoplasms of the Pancreas: A Surgical and Genetic Enigma. World J Surg 2017; 41(7): 1871-1881. https://doi.org/10.1007/s00268-017-3921-yTest.; Clancy T.E., Surgical Management of Pancreatic Neuroendocrine Tumors. Hematol Oncol Clin North Am 2016; 30(1): 103-18. https://doi.org/10.1016/j.hoc.2015.09.004Test.; Falconi M., Mantovani W., Crippa S., Mascetta G., Salvia R., Pederzoli P. Pancreatic insufficiency after different resections for benign tumours. Br J Surg 2008; 95(1): 85-91. https://doi.org/10.1002/bjs.5652Test.; Parekh J.R., Wang S.C., Bergsland E.K. et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas 2012; 41(6): 840-4. https://doi.org/10.1097/MPA.0b013e31823cdaa0Test.; Lee D.S., Jeffrey R.B., Kamaya A. Islet-cell tumors of the pancreas: spectrum of MDCT findings: a pictorial essay. Appl Radiol 2009; 38: 10–28.; Lewis R.B., Lattin G.E., Paal E. Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 2010; 30(6): 1445-64. https://doi.org/10.1148/rg.306105523Test.; Lee N.J., Hruban R.H., Fishman E.K. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance. Abdom Radiol 2018; 43: 3025-3034. https://doi.org/10.1007/s00261-018-1574-4Test.; Coleman K.M., Doherty M.C., Bigler S.A. Solid-pseudopapillary tumor of the pancreas. Radiographics. 2003; 23(6): 1644-8. https://doi.org/10.1148/rg.236035006Test.; Li D.L., Li H.S., Xu Y.K., Wang Q.S., Chen R.Y., Zhou F. Solid pseudopapillary tumor of the pancreas: clinical features and imaging findings. Clin Imaging 2018; 48: 113-121. https://doi.org/10.1016/j.clinimag.2017.10.006Test.; Canellas R., Lo G., Bhowmik S., Ferrone C., Sahani D. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery. J Magn Reson Imaging 2018; 47(2): 425-432. https://doi.org/10.1002/jmri.25756Test.; Kang C.M., Cho A., Kim H. et al. Clinical correlations with (18)FDG PET scan patterns in solid pseudopapillary tumors of the pancreas: still a surgical enigma? Pancreatology 2014;(6):515-23. https://doi.org/10.1016/j.pan.2014.08.003Test.; Matsumoto T., Okabe H., Yamashita YI. et al. Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography ((18)F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors. Surg Today 2019; 49(1): 21-26. https://doi.org/10.1007/s00595-018-1703-2Test.; Prasad V., Tiling N., Denecke T., Brenner W., Plöckinger U. Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease. Eur J Nucl Med Mol Imaging 2016; 43(11): 2014-20. https://doi.org/10.1007/s00259-016-3421-6Test.; Yu P.F., Hu ZH., Wang XB. et al. Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature. World J Gastroenterol 2010; 16(10): 1209-14. https://doi.org/10.3748/wjg.v16.i10.1209Test.; Zheng X., Tan X., Wu B. CT imaging features and their correlation with pathological findings of solid pseudopapillary tumor of pancreas. J Biomed Eng 2014; 31: 107-112.; Horiguchi S., Kato H., Shiraha H. Dynamic computed tomography is useful for prediction of pathological grade in pancreatic neuroendocrine neoplasm. J Gastroenterol Hepatol 2017; 32: 925-931. https://doi.org/10.1111/jgh.13594Test.; Kim D.W., Kim H.J., Kim K.W. et al. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 2015; 25: 1375-1383. https://doi.org/10.1007/s00330-014-3532-zTest.; Choi T.W., Kim T.W., Yu M.N., Park S.J., Han J.K. Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis. Acta Radiol 2018; 59: 383-392. https://doi.org/10.1177/0284185117725367Test.; Rodallec M., Vilgrain V., Couvelard A., et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 2006; 6: 77-85. https://doi.org/10.1159/000090026Test.; d’Assignies G., Couvelard A., Bahrami S. et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009; 250: 407-416. https://doi.org/10.1148/radiol.2501080291Test.; https://medvis.vidar.ru/jour/article/view/850Test

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Уральский медицинский журнал. 2019. Т. 172, № 4.; Риск заболеваемости злокачественными новообразованиями поджелудочной железы в когорте работников предприятия атомной промышленности / Г. В. Жунтова, Т. В. Азизова, Е. С. Григорьева [и др.]. – Текст: электронный // Уральский медицинский журнал. - 2019. – Т. 172, № 4. - С. 38-46.; http://elib.usma.ru/handle/usma/11382Test

  7. 7
    دورية أكاديمية
  8. 8
  9. 9
  10. 10